Pennsylvania Biotechnology Center (PABC) Press Releases

• Published on January 12, 2023 - 20:41 GMT

  

  Globally prominent advocate and physician chosen for Hepatitis B Foundation’s 2023 Community Commitment Award

  Su Wang, MD, MPH, who is a practicing physician in New Jersey, is one of the leading voices in the global hepatitis B community. DOYLESTOWN, PENNSYLVANIA, UNITED STATES, January 12, 2023 /⁨EINPresswire.com⁩/ -- The Hepatitis B Foundation, a global …

  Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
• Published on November 15, 2022 - 15:53 GMT

  

  German scientist, inventor of world’s 1st treatment for hepatitis D, chosen for Blumberg Prize by Hepatitis B Foundation

  Prof. Stephan Urban led development of the first treatment for hepatitis D, an often-fatal infection for millions of people worldwide. DOYLESTOWN, PENNSYLVANIA, UNITED STATES, November 15, 2022 /⁨EINPresswire.com⁩/ -- The Hepatitis B Foundation, a global …

  Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
• Published on October 31, 2022 - 15:45 GMT

  

  Blumberg Institute launches certificate program in Pharmaceutical Research & Development

  Drug inventor Dr. Kunwar Shailubhai leads the program, which he designed for early career professionals in the pharmaceutical and biotech industries. DOYLESTOWN, PA, USA, October 31, 2022 /⁨EINPresswire.com⁩/ -- The Baruch S. Blumberg Institute is …

  Distribution channels: Business & Economy, Education ...
• Published on October 14, 2022 - 18:58 GMT

  

  MERLIN Biotech wins pitch competition at Biotech Week Boston

  Dr. Randall N. Hyer, CEO of MERLIN and president of its parent, the Blumberg Institute, personally delivered the pitch. DOYLESTOWN, PENNSYLVANIA, UNITED STATES, October 14, 2022 /⁨EINPresswire.com⁩/ -- At Biotech Week Boston, one of the industry’s largest …

  Distribution channels: Business & Economy, Education ...
• Published on September 8, 2022 - 17:00 GMT

  

  Hepatitis B Foundation strongly supports Congressional letters urging Pres. Biden to end discriminatory military policy

  Rep. Mike Quigley leads the effort asking for inclusion of individuals living with well-managed hepatitis B and HIV in the military. DOYLESTOWN, PENNSYLVANIA, UNITED STATES, September 8, 2022 /⁨EINPresswire.com⁩/ -- The Hepatitis B Foundation, which has …

  Distribution channels: Aviation & Aerospace Industry, Healthcare & Pharmaceuticals Industry ...
• Published on August 11, 2022 - 16:30 GMT

  

  Blumberg Institute Laboratory dedicated to liver cancer research in memory of Johnson & Johnson Consumer Inc. manager

  Steven W. Miller, widely respected and loved by his colleagues at Johnson & Johnson Consumer Inc., died from liver cancer, which is difficult to diagnose. DOYLESTOWN, PENNSYLVANIA, UNITED STATES, August 11, 2022 /⁨EINPresswire.com⁩/ -- Steven W. …

  Distribution channels: Consumer Goods, Education ...
• Published on June 21, 2022 - 19:02 GMT

  

  Former Moderna executive, Randall N. Hyer, MD, PhD, MPH, named president of the Baruch S. Blumberg Institute

  The Institute is the world’s only nonprofit research organization dedicated to hepatitis B and liver cancer research. DOYLESTOWN, PENNSYLVANIA, UNITED STATES, June 21, 2022 /⁨EINPresswire.com⁩/ -- The Baruch S. Blumberg Institute’s Board of Directors has …

  Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
• Published on May 24, 2022 - 13:00 GMT

  Hepatitis B Foundation, StoryCenter release new #justB stories from people with lived experience

  For Hepatitis Awareness Month, the Hepatitis B Foundation has released five new videos as part of its national #justB storytelling campaign. DOYLESTOWN, PENNSYLVANIA, UNITED STATES, May 24, 2022 /⁨EINPresswire.com⁩/ -- For Hepatitis Awareness Month, the …

  Distribution channels: Culture, Society & Lifestyle, Education ...
• Published on April 22, 2022 - 15:30 GMT

  

  Blumberg Institute launches MERLIN Biotech, a spinout company leveraging mRNA technology for therapeutics and vaccines

  Dr. Randall N. Hyer, former senior vice president for global medical affairs at Moderna, is chief executive officer. DOYLESTOWN, PENNSYLVANIA, UNITED STATES, April 22, 2022 /⁨EINPresswire.com⁩/ -- The Baruch S. Blumberg Institute has announced the launch …

  Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
• Published on March 31, 2022 - 22:00 GMT

  

  Many more U.S. adults to get vaccinated against hepatitis B following move by CDC

  The Hepatitis B Foundation and partners are forming an advisory council to promote implementation of the CDC’s new hepatitis B vaccination recommendations. NEWTOWN, PA, UNITED STATES, March 31, 2022 /⁨EINPresswire.com⁩/ -- The Hepatitis B Foundation …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Insurance Industry ...
• Published on February 3, 2022 - 13:00 GMT

  

  Randall N. Hyer, MD, PhD, MPH, joins the Blumberg Institute faculty

  A former Moderna executive, Dr. Hyer played a key role in launching the company’s COVID-19 vaccine. DOYLESTOWN, PA, USA, February 3, 2022 /⁨EINPresswire.com⁩/ -- Randall N. Hyer, MD, PhD, MPH, former senior vice president for global medical affairs at …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on January 27, 2022 - 17:00 GMT

  

  California-based biotech expands R&D footprint at the Pennsylvania Biotechnology Center (PABC)

  IGM Biosciences business units are pioneering the development of therapeutic IgM antibodies for infectious, autoimmune and inflammatory diseases. DOYLESTOWN, PENNSYLVANIA, UNITED STATES, January 27, 2022 /⁨EINPresswire.com⁩/ -- The nonprofit Pennsylvania …

  Distribution channels: Banking, Finance & Investment Industry, Companies ...